|
DE144266C
(cg-RX-API-DMAC7.html)
|
|
|
|
|
|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3177206A
(en)
|
1963-03-07 |
1965-04-06 |
American Home Prod |
Selective bromination of a-ring aromatic 17-ketalized steroids
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US3673180A
(en)
|
1970-06-18 |
1972-06-27 |
Merck & Co Inc |
19-nor-6,6-ethylene-20-spiroxenes
|
|
US4792620A
(en)
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
|
US4739078A
(en)
|
1984-02-17 |
1988-04-19 |
The Upjohn Company |
Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
|
|
IE60780B1
(en)
|
1987-01-23 |
1994-08-10 |
Akzo Nv |
New 11-aryl steroid derivatives
|
|
DE3710728A1
(de)
|
1987-03-31 |
1988-10-13 |
Schering Ag |
Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
WO2002094276A1
(en)
|
2001-05-18 |
2002-11-28 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
ES2296943T3
(es)
|
2001-05-23 |
2008-05-01 |
Pantarhei Bioscience B.V. |
Sistema de administracion de un medicamento estrogeno tetrahidroxilado destinado a la contracepcion hormonal.
|
|
ATE449606T1
(de)
|
2001-05-23 |
2009-12-15 |
Pantarhei Bioscience Bv |
Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
CA2467222C
(en)
|
2001-11-15 |
2010-06-08 |
Herman Jan Tijmen Coelingh Bennink |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
PL209558B1
(pl)
|
2002-02-21 |
2011-09-30 |
Bayer Schering Pharma Ag |
Zestaw zawierający steroid, składnik tetrahydrofolianowy i witaminę B12 do zastosowania w metodzie hormonalnej antykoncepcji lub hormonalnej terapii zastępczej
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
ES2399423T3
(es)
|
2002-06-11 |
2013-04-01 |
Pantarhei Bioscience B.V. |
Método para tratar la piel humana y una composición para el cuidado de la piel para su uso en tal método
|
|
ATE340579T1
(de)
|
2002-06-11 |
2006-10-15 |
Pantarhei Bioscience Bv |
Methode zur behandlung oder prävention immunologischer erkrankungen und pharmazeutische zusammensetzung zur solchen anwendung
|
|
ES2299730T3
(es)
|
2002-07-12 |
2008-06-01 |
Pantarhei Bioscience B.V. |
Composicion farmaceutica que comprende derivados de estetrol para el uso en la terapia del cancer.
|
|
DE60318092T2
(de)
|
2002-10-23 |
2008-11-27 |
Pantarhei Bioscience B.V. |
Pharmazeutische zusammensetzung enthaltend estetrolderivate und anwendung in der krebsbehandlung
|
|
EP1562976B1
(en)
*
|
2002-11-08 |
2010-05-26 |
Pantarhei Bioscience B.V. |
Synthesis of estetrol via estrone derived steroids
|
|
DK1624878T3
(da)
|
2003-05-22 |
2007-01-08 |
Pantarhei Bioscience Bv |
Anvendelse af præparater som omfatter en östrogen komponent til behandling og forebyggelse af muskel-skelet-smerte
|
|
CN102796160A
(zh)
|
2005-05-26 |
2012-11-28 |
索尔瓦药物有限公司 |
17β-HSD1和STS抑制剂
|
|
DE502006007749D1
(de)
|
2005-07-25 |
2010-10-07 |
Riboxx Gmbh |
Verfahren und Kit zur Amplifikation von heteropolymerer oder poly(C)- RNA
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
US20090221540A1
(en)
|
2006-01-09 |
2009-09-03 |
Pantarhei Bioscience B.V. |
Method of Treating An Acute Vascular Disorder
|
|
WO2007146805A2
(en)
|
2006-06-08 |
2007-12-21 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
|
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
GB0621926D0
(en)
|
2006-11-03 |
2006-12-13 |
Medlock Medical Ltd |
Multi directional stretch tubular bandages
|
|
EP2086550A2
(en)
|
2006-11-29 |
2009-08-12 |
Wyeth |
Estrogen/ serm and estrogen/ progestin bi-layer tablets
|
|
WO2008079245A2
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
DE602008001783D1
(de)
*
|
2007-01-08 |
2010-08-26 |
Pantarhei Bioscience Bv |
Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
|
|
US20080175908A1
(en)
|
2007-01-12 |
2008-07-24 |
Wyeth |
Tablet-in-tablet compositions
|
|
ATE537833T1
(de)
|
2007-06-21 |
2012-01-15 |
Pantarhei Bioscience Bv |
Behandlung des mekoniumaspirationssyndroms mit östrogenen
|
|
US8518923B2
(en)
|
2007-07-19 |
2013-08-27 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
EP2085373B8
(en)
|
2007-08-31 |
2013-06-26 |
National University Corporation Nagoya University |
Method for producing carbonyl compound and pro-oxidant used for production of carbonyl compound
|
|
EP2077272A1
(en)
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
|
US20110250274A1
(en)
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
EP2714712B1
(en)
|
2011-06-01 |
2016-08-24 |
Estetra S.P.R.L. |
Process for the production of estetrol intermediates
|
|
PL2714710T3
(pl)
|
2011-06-01 |
2017-03-31 |
Estetra S.P.R.L. |
Sposób wytwarzania estetrolowych związków pośrednich
|
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
KR102033187B1
(ko)
|
2011-07-19 |
2019-10-16 |
판타레이 바이오사이언스 비.브이. |
디하이드로에피안드로스테론(ｄｈｅａ)을 함유하는 정제
|
|
US9579329B2
(en)
|
2011-08-11 |
2017-02-28 |
Estetra S.P.R.L. |
Use of estetrol as emergency contraceptive
|
|
US9731018B2
(en)
|
2011-09-16 |
2017-08-15 |
Ferring B.V. |
Fast dissolving pharmaceutical composition
|
|
EA024003B1
(ru)
|
2011-10-07 |
2016-08-31 |
Эстетра С.П.Р.Л. |
Способ получения эстетрола
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
ES2624667T3
(es)
|
2013-09-18 |
2017-07-17 |
Crystal Pharma, S.A.U. |
Procedimiento para la preparación de estetrol
|
|
HRP20180129T1
(hr)
|
2013-12-12 |
2018-02-23 |
Donesta Bioscience B.V. |
Oralno raspadajuća čvrsta jedinica doze koja sadrži estetrol komponentu
|
|
CA2988362C
(en)
|
2015-06-18 |
2022-07-19 |
Mithra Pharmaceuticals S.A. |
Orodispersible tablet containing estetrol
|
|
PT3310333T
(pt)
|
2015-06-18 |
2020-06-08 |
Estetra Sprl |
Dose unitária orodispersível contendo um composto de estetrol
|
|
TN2017000499A1
(en)
|
2015-06-18 |
2019-04-12 |
Mithra Pharmaceuticals S A |
Orodispersible dosage unit containing an estetrol component
|
|
JP6866561B2
(ja)
|
2015-06-18 |
2021-04-28 |
エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ |
エステトロールを含有する口腔内崩壊錠
|